TWi Biotechnology, Inc. (6610.TWO)
TWD 13.9
(-4.14%)
TWD 13.9
(-4.14%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 7.97 Million TWD | 215.31% |
| 2022 | 2.52 Million TWD | -49.67% |
| 2021 | 5.02 Million TWD | -32.9% |
| 2020 | 7.48 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.28 Million TWD | 61.35% |
| 2024 Q1 | 4.28 Million TWD | -46.28% |
| 2023 Q1 | - TWD | -100.0% |
| 2023 Q2 | 1.26 Million TWD | 0.0% |
| 2023 FY | 7.97 Million TWD | 215.31% |
| 2023 Q4 | 7.97 Million TWD | 42.26% |
| 2023 Q3 | 5.6 Million TWD | 341.88% |
| 2022 Q3 | - TWD | 0.0% |
| 2022 Q4 | 2.52 Million TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 97.189% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 40.171% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 97.033% |
| NaviFUS Corp. | 32.69 Million TWD | 75.619% |
| TaiRx, Inc. | 12.28 Million TWD | 35.121% |
| Sinew Pharma Inc. | 6.46 Million TWD | -23.314% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 70.609% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -580.7% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 95.936% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 36.788% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -476.356% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 98.021% |
| AP Biosciences Inc | 82.07 Million TWD | 90.289% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 95.421% |
| RBC Bioscience Corporation | 487.36 Million TWD | 98.364% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.831% |
| EirGenix Inc. | 465.16 Million TWD | 98.286% |
| Enimmune corporation | 45.73 Million TWD | 82.571% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 90.345% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -121.91% |
| 3D Global Biotech Inc. | 10.37 Million TWD | 23.201% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 94.479% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 98.938% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 98.902% |
| TCI GENE Inc. | 6.79 Million TWD | -17.307% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -277.058% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 97.997% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -83.073% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | 26.181% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 91.773% |
| Neith Corporation | 3.54 Million TWD | -125.106% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 97.964% |
| VBI | - TWD | -Infinity% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 92.974% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -35.148% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -816.207% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -46.769% |
| Lin BioScience, Inc. | 42.87 Million TWD | 81.408% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 96.899% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -1381.599% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Visgeneer Inc. | 158.6 Million TWD | 94.974% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 86.306% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 4.172% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 98.089% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 39.115% |
| GlycoNex Incorporation | 900 Thousand TWD | -785.667% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.726% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.445% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 97.51% |
| BiOptic Inc. | 93.19 Million TWD | 91.447% |
| PharmaEngine, Inc. | 14.8 Million TWD | 46.175% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | 16.977% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 89.327% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 25.379% |
| OBI Pharma, Inc. | 501.05 Million TWD | 98.409% |
| Savior Lifetec Corporation | 270.37 Million TWD | 97.052% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 44.55% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.596% |
| Level Biotechnology Inc. | 13.5 Million TWD | 40.964% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 76.583% |
| Acepodia, Inc. | 273.81 Million TWD | 97.089% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 61.037% |